Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-23-019619

President & CEO gave up 117,667 shares (to pay taxes)

  • President & CEO acquired 196,746 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Simon, Christopher · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-29 Exercise or conversion : show line 1 in the form +196,746 $28.62 $5,629,887 414,113 D
2023-06-29 Shares withheld for taxes : show line 2 in the form −117,667 $84.84 $9,982,868 296,446 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-29 Exercise or conversion : show line 3 in the form Non-qualified Stock Option (Right to Buy) −196,746 0 D
Loading xslF345X04/form4.xml…